Neuroscientific Biopharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neuroscientific biopharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neuroscientific Biopharmaceuticals Today - Breaking & Trending Today

NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

With its stock down 48% over the past three months, it is easy to disregard NeuroScientific Biopharmaceuticals. ....

Neuroscientific Biopharmaceutical , Scientific Biopharmaceuticals , Neuroscientific Biopharmaceuticals ,

18 Share Tips | 4th September 2023

Take a look at the buy, hold and sell recommendations for the week of 4th September 2023 from 3 top experts. ....

New Zealand , Western Australia , New South Wales , New Zealand General , Sams Creek , Republic Of Niger , Tim Haselum , Michael Gable , Woolworths Group , Telstra Group , Washingtonh Soul Pattinson Company , Costa Group Holdings , Fortescue Metals Group , Insurance Group , Charter Hall Group , Jonathan Lodge , Resmed Inc , Critical Minerals Group , Charter Hall Long , Northern Star Resources , Washingtonh Soul Pattinson , Paine Schwartz Partners , Iceni Gold , Laverton Greenstone , Siren Gold , Neuroscientific Biopharmaceuticals ,

NeuroScientific Biopharmaceuticals Limited (ASX:NSB) Insider Stephen Quantrill Purchases 180,000 Shares

NeuroScientific Biopharmaceuticals Limited (ASX:NSB – Get Free Report) insider Stephen Quantrill bought 180,000 shares of the stock in a transaction on Tuesday, July 4th. The stock was purchased at an average cost of A$0.10 ($0.06) per share, for a total transaction of A$17,460.00 ($11,640.00). NeuroScientific Biopharmaceuticals Price Performance About NeuroScientific Biopharmaceuticals (Get Free Report) NeuroScientific […] ....

Stephen Quantrill , Neuroscientific Biopharmaceuticals Limited , Neuroscientific Biopharmaceuticals , Get Free Report , Scientific Biopharmaceuticals Limited , Neuroscientific Biopharmaceuticals Daily ,

Insider Buying: NeuroScientific Biopharmaceuticals Limited (ASX:NSB) Insider Purchases 180,000 Shares of Stock

NeuroScientific Biopharmaceuticals Limited (ASX:NSB – Free Report) insider Stephen Quantrill acquired 180,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 4th. The stock was acquired at an average price of A$0.10 ($0.06) per share, with a total value of A$17,460.00 ($11,640.00). NeuroScientific Biopharmaceuticals Stock Performance About NeuroScientific Biopharmaceuticals (Free Report) […] ....

Stephen Quantrill , Neuroscientific Biopharmaceuticals Limited , Neuroscientific Biopharmaceuticals , Free Report , Scientific Biopharmaceuticals Limited , Neuroscientific Biopharmaceuticals Daily ,

NeuroScientific Biopharmaceuticals Limited (ASX:NSB) Insider Buys A$22,276.15 in Stock

NeuroScientific Biopharmaceuticals Limited (ASX:NSB – Get Rating) insider Paul Rennie purchased 229,651 shares of NeuroScientific Biopharmaceuticals stock in a transaction dated Wednesday, May 24th. The stock was bought at an average cost of A$0.10 ($0.06) per share, with a total value of A$22,276.15 ($14,559.57). Paul Rennie also recently made the following trade(s): On Wednesday, May […] ....

Paul Rennie , Neuroscientific Biopharmaceuticals , Neuroscientific Biopharmaceuticals Company Profile , Neuroscientific Biopharmaceuticals Limited , Get Rating , Scientific Biopharmaceuticals Limited , Neuroscientific Biopharmaceuticals Daily , Asx Nsb , Insider Trading , Nsider Trades ,